NASDAQ: ZURA
Zura Bio Ltd Stock

$1.51-0.15 (-9.04%)
Updated Feb 10, 2025
ZURA Price
$1.51
Fair Value Price
$3.02
Market Cap
$98.59M
52 Week Low
$1.49
52 Week High
$6.35
P/E
-4.72x
P/B
0.64x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$47.25M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.12
Operating Cash Flow
-$21M
Beta
-0.16
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ZURA Overview

JATT Acquisition Corporation is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the life sciences sector. JATT Acquisition was incorporated in 2021 and is based in Grand Cayman, Cayman Islands.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ZURA's potential to beat the market

FStrong Sell
  • Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More

Zen Rating Component Grades

C
Value
C
Growth
D
Momentum
D
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
ZURA
Ranked
#507 of 557

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important ZURA news, forecast changes, insider trades & much more!

ZURA News

Overview

Due Diligence Score

–
Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ZURA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ZURA ($1.51) is undervalued by 49.98% relative to our estimate of its Fair Value price of $3.02 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ZURA ($1.51) is significantly undervalued by 49.98% relative to our estimate of its Fair Value price of $3.02 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ZURA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ZURA due diligence checks available for Premium users.

Valuation

ZURA fair value

Fair Value of ZURA stock based on Discounted Cash Flow (DCF)

Price
$1.51
Fair Value
$3.02
Undervalued by
49.98%
ZURA ($1.51) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ZURA ($1.51) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ZURA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ZURA price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-4.72x
Industry
-154.48x
Market
31x

ZURA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.64x
Industry
4.86x
ZURA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ZURA's financial health

Profit margin

Revenue
$0.0
Net Income
-$20.7M
Profit Margin
0%
ZURA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$189.1M
Liabilities
$18.2M
Debt to equity
0.12
ZURA's short-term assets ($188.98M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZURA's short-term assets ($188.98M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZURA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.7M
Investing
-$13.0k
Financing
$5.4M
ZURA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ZURA vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ZURAF$98.59M-9.04%-4.72x0.64x
ARTVC$98.13M+3.32%N/A0.49x
EDITF$99.06M-4.00%-0.47x0.56x
ALGSC$99.38M+0.62%-3.78x1.98x
ANIXC$97.56M-4.11%-7.77x4.88x

Zura Bio Stock FAQ

What is Zura Bio's quote symbol?

(NASDAQ: ZURA) Zura Bio trades on the NASDAQ under the ticker symbol ZURA. Zura Bio stock quotes can also be displayed as NASDAQ: ZURA.

If you're new to stock investing, here's how to buy Zura Bio stock.

What is the 52 week high and low for Zura Bio (NASDAQ: ZURA)?

(NASDAQ: ZURA) Zura Bio's 52-week high was $6.35, and its 52-week low was $1.49. It is currently -76.22% from its 52-week high and 1.34% from its 52-week low.

How much is Zura Bio stock worth today?

(NASDAQ: ZURA) Zura Bio currently has 65,293,530 outstanding shares. With Zura Bio stock trading at $1.51 per share, the total value of Zura Bio stock (market capitalization) is $98.59M.

Zura Bio stock was originally listed at a price of $9.95 in Jul 14, 2021. If you had invested in Zura Bio stock at $9.95, your return over the last 3 years would have been -84.82%, for an annualized return of -46.66% (not including any dividends or dividend reinvestments).

How much is Zura Bio's stock price per share?

(NASDAQ: ZURA) Zura Bio stock price per share is $1.51 today (as of Feb 10, 2025).

What is Zura Bio's Market Cap?

(NASDAQ: ZURA) Zura Bio's market cap is $98.59M, as of Feb 11, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Zura Bio's market cap is calculated by multiplying ZURA's current stock price of $1.51 by ZURA's total outstanding shares of 65,293,530.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.